CA2719855A1 - Hydrogel et copolymeres sequences thermosensibles - Google Patents

Hydrogel et copolymeres sequences thermosensibles Download PDF

Info

Publication number
CA2719855A1
CA2719855A1 CA2719855A CA2719855A CA2719855A1 CA 2719855 A1 CA2719855 A1 CA 2719855A1 CA 2719855 A CA2719855 A CA 2719855A CA 2719855 A CA2719855 A CA 2719855A CA 2719855 A1 CA2719855 A1 CA 2719855A1
Authority
CA
Canada
Prior art keywords
block
molecular weight
average molecular
block copolymer
number average
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2719855A
Other languages
English (en)
Inventor
Ren-Ke Li
Sam Zeng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Health Network
Original Assignee
University Health Network
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Health Network filed Critical University Health Network
Priority to CA2719855A priority Critical patent/CA2719855A1/fr
Priority to PCT/IB2011/002953 priority patent/WO2012059820A1/fr
Publication of CA2719855A1 publication Critical patent/CA2719855A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78—Preparation processes
    • C08G63/82—Preparation processes characterised by the catalyst used
    • C08G63/823—Preparation processes characterised by the catalyst used for the preparation of polylactones or polylactides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
CA2719855A 2010-11-02 2010-11-02 Hydrogel et copolymeres sequences thermosensibles Abandoned CA2719855A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA2719855A CA2719855A1 (fr) 2010-11-02 2010-11-02 Hydrogel et copolymeres sequences thermosensibles
PCT/IB2011/002953 WO2012059820A1 (fr) 2010-11-02 2011-11-02 Hydrogel sensible à la température et copolymères séquencés

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2719855A CA2719855A1 (fr) 2010-11-02 2010-11-02 Hydrogel et copolymeres sequences thermosensibles

Publications (1)

Publication Number Publication Date
CA2719855A1 true CA2719855A1 (fr) 2012-05-02

Family

ID=46020970

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2719855A Abandoned CA2719855A1 (fr) 2010-11-02 2010-11-02 Hydrogel et copolymeres sequences thermosensibles

Country Status (2)

Country Link
CA (1) CA2719855A1 (fr)
WO (1) WO2012059820A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8633296B1 (en) * 2012-09-12 2014-01-21 International Business Machines Corporation Composite hydrogels for delivery of biologically active materials
CN108148204B (zh) * 2017-12-21 2020-10-20 广东永诺医疗科技有限公司 全氟聚醚-聚乙二醇嵌段式共聚物、制备方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117949A (en) * 1998-10-01 2000-09-12 Macromed, Inc. Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
KR100668046B1 (ko) * 2006-03-15 2007-01-16 한국화학연구원 생체적합성 및 온도감응성의 폴리에틸렌글리콜/폴리에스터블록 공중합체 및 이의 제조방법

Also Published As

Publication number Publication date
WO2012059820A1 (fr) 2012-05-10

Similar Documents

Publication Publication Date Title
US20120164100A1 (en) Temperature sensitive hydrogel and block copolymers
KR100633939B1 (ko) 가역적 열 겔화 성질을 갖는 생분해성 저분자량 트리블럭폴리(락티드-코-글리콜리드) 폴리에틸렌 글리콜 공중합체
JP4187789B2 (ja) ポリ（エーテル−エステル）ブロックポリマーを基剤とする感熱生分解性ポリマー
KR100558025B1 (ko) 가역성 열 젤화 특성을 보유한 생분해성 저분자량 삼블록폴리에스테르 폴리에틸렌 글리콜 공중합체
US8535705B2 (en) Biocompatible polymers and hydrogels and methods of use
AU2001294828B2 (en) Thermogelling biodegradable aqueous polymer solution
JP3126637B2 (ja) 生体適合性ブロックコポリマー
ES2395732T3 (es) Composición polimérica multi-bloque biodegradable susceptible de transición sol-gel
EP2050473B1 (fr) Dispositif de livraison de médicaments
JP2009531471A (ja) 生分解性及び温度感応性ポリ有機フォスファゼンの製造方法及び用途
JP5171146B2 (ja) 温度応答性を有する生分解性ポリマー及びその製造方法
JPH11510837A (ja) 薬物送達のための制御された放出薬剤および組織処置薬剤としての使用のためのマルチブロック生分解性ヒドロゲル
KR20050058291A (ko) 약물 전달을 위한 생분해가능 블록 공중합성 조성물
CN100427144C (zh) 一种可降解的温敏性物理水凝胶及其制备方法
US20150099808A1 (en) Amphiphilic copolymers and compositions containing such polymers
Wu et al. Decisive influence of hydrophobic side chains of polyesters on thermoinduced gelation of triblock copolymer aqueous solutions
JP5653441B2 (ja) 再構成可能な逆熱ゲル化性ポリマー
KR20080017850A (ko) 온도 민감성 졸-젤 전이 폴리에틸렌글리콜/폴리펩티드 블록공중합체, 이의 제조 방법 및 이의 의학적 응용
JP5019851B2 (ja) 温度応答性ゾル−ゲル転移を示す生分解性ポリマー及びその製造方法
CA2719855A1 (fr) Hydrogel et copolymeres sequences thermosensibles
JP6176998B2 (ja) 温度応答性生分解性高分子組成物及びその製造方法
CN102453244A (zh) 温敏性可生物降解聚(聚醚酯二酸)酐多嵌段共聚物及其水凝胶体系和应用
Censi et al. In‐Situ Gelling Thermosensitive Hydrogels for Protein Delivery Applications
CA2235413C (fr) Polymeres biodegradables thermosensible a base de copolymeres a sequence poly(ether-ester)
CA2637524C (fr) Dispositif d'administration de medicaments

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20151103